Abstract
General anesthesia is viewed from two angles in this chapter: adverse effects on the brain and use of some anesthetic agents as neuroprotectives, with focus on the latter. There is a particular concern about neurotoxicity of general anesthetics on the developing brain during anesthesia in pregnant women. Neurological complications of general anesthesia have been described elsewhere (Jain 2010b). General anesthesia carries a risk of stroke in elderly hypertensive patients, particularly in those with stenotic lesions of the cerebral arteries and those with incidental or induced hypotension. This is more to do with techniques and the physiological responses, which may result in hypotension or inadequate oxygenation. In spite of all the modern monitoring techniques, it is not possible to avoid an episode of cerebrovascular ischemia during general anesthesia. Complications of carotid endarterectomy during local or regional anesthesia are distinctly less than those under general anesthesia. One of the reasons is that general anesthesia deprives the possibility of clinical neurological assessment requiring patient cooperation and responses. However, agents used for anesthesia have a neuroprotective effect, which will be discussed in the following section.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Ruzzeh S, George S, Bustami M, et al. Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes: randomised controlled trial. BMJ 2006;332:1365.
Dickinson R, Franks NP. Bench-to-bedside review: molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit Care 2010;14:229.
Erickson KM, Pasternak JJ, Weglinski MW, et al. Temperature management in studies of barbiturate protection from focal cerebral ischemia: systematic review and speculative synthesis. J Neurosurg Anesthesiol 2009;21:307–17.
Gerriets T, Schwarz N, Sammer G, et al. Protecting the brain from gaseous and solid micro-emboli during coronary artery bypass grafting: a randomized controlled trial. Eur Heart J 2010;31:360–8.
Homi HM, Yokoo N, Ma D, et al. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003;99:876–81.
Jadhav V, Solaroglu I, Obenaus A, Zhang JH. Neuroprotection against surgically induced brain injury. Surg Neurol 2007;67:15–20.
Jadhav V, Ostrowski RP, Tong W, et al. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury. Stroke 2009;40:3139–42.
Jain KK. Surgical treatment of unruptured intracranial aneurysms. Acta Neurochir 1982;66:187–94.
Jain KK. Treatment of Cerebral Vasospasm. Medlink Corporation, San Diego, California, 2010a.
Jain KK. Neurologic complications of general anesthesia. In, Gilman S (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2010b.
Jain KK. Neurologic complications of local anesthesthetics. In, Gilman S (ed) MedLink Neurology. Medlink Publishing Corporation, San Diego, California, 2010c.
Kellermann K, Jungwirth B. Avoiding stroke during cardiac surgery. Semin Cardiothorac Vasc Anesth 2010;14:95–101.
Kemmling A, Duning T, Lemcke L, et al. Case report of MR perfusion imaging in Sinking Skin Flap Syndrome: growing evidence for hemodynamic impairment. BMC Neurol 2010;10:80.
Lakic N, Surlan K, Jerin A, et al. Importance of erythropoietin in brain protection aft er cardiac surgery: a pilot study. Heart Surg Forum 2010;13:E185–9.
McKhann GM, Grega MA, Borowicz LM Jr, et al. Stroke and encephalopathy after cardiac surgery: an update. Stroke 2006;37:562–71.
Pajewski TN, Arlet V, Phillips LH. Current approach on spinal cord monitoring: the point of view of the neurologist, the anesthesiologist and the spine surgeon. Eur Spine J 2007;16 Suppl 2:S115–29.
Pradilla G, Chaichana KL, Hoang S, et al. Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am 2010;21:365–79.
Rossaint J, Rossaint R, Weis J, et al. Propofol: neuroprotection in an in vitro model of traumatic brain injury. Crit Care 2009;13(2):R61.
Schorl M. Sinking skin flap syndrome (SSFS) – clinical spectrum and impact on rehabilitation. Cen Eur Neurosurg 2009;70:68–72.
Sehdev RS, Symmons DA, Kindl K. Ketamine for rapid sequence induction in patients with head injury in the emergency department. Emerg Med Australas 2006;18:37–44.
Shibuta S, Varathan S, Mashimo T. Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide. Br J Anaesth 2006;97:517–24.
Sutter MA, Eggspuehler A, Grob D, et al. Multimodal intraoperative monitoring (MIOM) during 409 lumbosacral surgical procedures in 409 patients. Eur Spine J 2007;16 Suppl 2:S221–8.
Todd MM, Hindman BJ, Clarke WR, Torner JC. Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005;352:135–45.
Weigl M, Tenze G, Steinlechner B, et al. A systematic review of currently available pharmacological neuroprotective agents as a sole intervention before anticipated or induced cardiac arrest. Resuscitation 2005;65:21–39.
Zausinger S, Westermaier T, Plesnila N, et al. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen. Stroke 2003;34:1526–32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jain, K.K. (2011). Neuroprotection During Anesthesia and Surgery. In: The Handbook of Neuroprotection. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-049-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-61779-049-2_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-048-5
Online ISBN: 978-1-61779-049-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)